Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cleopatra Hospital CoCAI:CLHO 87 Equity-to-Asset is 0.34 as of Mar. 2026, which is 40% below its 10-year median of 0.57. GuruFocus rates CAI:CLHO with a GF Score™ of 87/100 and a GF Value™ of E£14.72 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Cleopatra Hospital Co ranks worse than 67.1% on this metric.
The historical rank and industry rank for Cleopatra Hospital Co's Equity-to-Asset or its related term are showing as below:
CAI:CLHO'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.2 Med: 0.57 Max: 0.76
Current: 0.34
During the past 11 years, the highest Equity to Asset Ratio of Cleopatra Hospital Co was 0.76. The lowest was 0.20. And the median was 0.57.
CAI:CLHO's Equity-to-Asset is ranked worse than 67.1% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs CAI:CLHO: 0.34
Cleopatra Hospital Co (CAI:CLHO) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Cleopatra Hospital Co Equity-to-Asset Related Terms
Cleopatra Hospital Co Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Cleopatra Hospital Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAI:CLHO vs HCA, THC, DVA: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Cleopatra Hospital Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cleopatra Hospital Co Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cleopatra Hospital Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Cleopatra Hospital Co's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Cleopatra Hospital Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cleopatra Hospital Co (CAI:CLHO) has a Equity-to-Asset of 0.34 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cleopatra Hospital Co and its competitors. This is 40% below median its historical median of 0.57. Over the past decade, Cleopatra Hospital Co's Equity-to-Asset has ranged from 0.20 to 0.76. According to the industry distribution chart, Cleopatra Hospital Co ranks #461 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 67.1%.
Is Cleopatra Hospital Co's Equity-to-Asset too high?
Cleopatra Hospital Co's current Equity-to-Asset of 0.34 is 40% below median its 10-year median of 0.57. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 0.76. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Cleopatra Hospital Co's value of 0.34 is 29.2% below this industry median. Based on the distribution chart, Cleopatra Hospital Co ranks #461 out of 687 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cleopatra Hospital Co has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Cleopatra Hospital Co ranks #461 out of 687 companies for Equity-to-Asset. This places Cleopatra Hospital Co in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Cleopatra Hospital Co's value of 0.34 is 29.2% below this benchmark. Historically, Cleopatra Hospital Co's own Equity-to-Asset has ranged from 0.20 to 0.76 over the past decade. While the company's 10-year median is 0.57 vs. the industry median of 0.48, Cleopatra Hospital Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cleopatra Hospital Co's current Equity-to-Asset of 0.34 is 29.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cleopatra Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleopatra Hospital Co's current Equity-to-Asset is 0.34, which is 40% below median its own 10-year median of 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£14.72, compared to a current price of E£17.50 — trading 18.9% above its estimated fair value. The current Equity-to-Asset is 0.34, which is 40% below median its 10-year median of 0.57 and 29.2% below the Healthcare Providers & Services industry median of 0.48. Cleopatra Hospital Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current Equity-to-Asset is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?
Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued.
The current stock price of E£17.50 is trading 18.9% above its estimated GF Value™ of E£14.72.
GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.
Key valuation signals for CAI:CLHO:
Equity-to-Asset: 0.34 (40% below median its 10-year median of 0.57)
GF Value™: E£14.72 vs. price of E£17.50 (18.9% above fair value)
Industry Position: 29.2% below the Healthcare Providers & Services median (#461 of 687)
No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
87GF Score
Get the complete analysis for CAI:CLHO
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:CLHO has been successfully added to your 
